These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 19466429)

  • 1. Decipher Score predicts prostate specific antigen persistence after prostatectomy.
    Treacy PJ; Falagario UG; Magniez F; Ratnani P; Wajswol E; Martini A; Jambor I; Wiklund P; Bentellis I; Barthe F; Kyprianou N; Durand M; Steffens D; Karunaratne S; Leslie S; Thanigasalam R; Tewari A
    Minerva Urol Nephrol; 2023 Oct; 75(5):583-590. PubMed ID: 37728494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Pre-Operative Total Prostate-Specific Antigen and Survivorship of Prostate Cancer following Radical Prostatectomy: A Systematic Review.
    Okwor CJ; Okwor VC; Meka IA; Emedoh AE; Nweke M
    Med Princ Pract; 2024; 33(2):102-111. PubMed ID: 38142683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of Time Until PSA Recurrence After Radical Prostatectomy Without Neo- or Adjuvant Treatment to Clinical Progression and Cancer-Related Death in High-Risk Prostate Cancer Patients.
    Venclovas Z; Jievaltas M; Milonas D
    Front Oncol; 2019; 9():1286. PubMed ID: 31824859
    [No Abstract]   [Full Text] [Related]  

  • 4. The role for surgery in high-risk prostate cancer.
    Lanchon C; F Shariat S; Rouprêt M
    Wien Med Wochenschr; 2015 Oct; 165(19-20):395-400. PubMed ID: 26399721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of oncologic outcomes after radical prostatectomy in men diagnosed with prostate cancer with PSA levels below and above 4 ng/mL.
    Dariane C; Le Cossec C; Drouin SJ; Wolff B; Granger B; Mozer P; Bitker MO; Shariat SF; Cussenot O; Rouprêt M
    World J Urol; 2014 Apr; 32(2):481-7. PubMed ID: 23619479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radical Prostatectomy as a First-Line Treatment in Patients with Initial PSA  >20 ng/mL.
    Hinev AI; Anakievski D; Hadjiev VI
    Int J Surg Oncol; 2012; 2012():832974. PubMed ID: 22888416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological findings and oncological control afforded by radical prostatectomy in men with high-risk prostate cancer: a single-centre study.
    Masson-Lecomte A; Hupertan V; Comperat E; Vaessen C; Chartier-Kastler E; Cussenot O; Bitker MO; Rouprêt M
    World J Urol; 2011 Oct; 29(5):665-70. PubMed ID: 21072635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncologic outcome after radical prostatectomy in men with PSA values above 20 ng/ml: a monocentric experience.
    Nguyen K; Eltz S; Drouin SJ; Comperat E; Audenet F; Renard-Penna R; Bitker MO; Chartier-Kastler E; Richard F; Cussenot O; Rouprêt M
    World J Urol; 2009 Oct; 27(5):653-8. PubMed ID: 19466429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
    Kupelian PA; Katcher J; Levin HS; Klein EA
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.
    Kupelian P; Katcher J; Levin H; Zippe C; Klein E
    Urology; 1996 Aug; 48(2):249-60. PubMed ID: 8753737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncologic control obtained after radical prostatectomy in men with a pathological Gleason score ≥ 8: a single-center experience.
    Audenet F; Comperat E; Seringe E; Drouin SJ; Richard F; Cussenot O; Bitker MO; Rouprêt M
    Urol Oncol; 2011; 29(6):602-7. PubMed ID: 19926312
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.